Mutations in LMNA Modulate the Lamin A - Nesprin-2 Interaction and Cause LINC Complex Alterations

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Yang, Liu ^a   Munck, Martina ^a   Swaminathan, Karthic ^a   Kapinos, Larisa E ^b   Noegel, Angelika A ^a   Neumann, Sascha ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CYSTEINE; CYTOSKELETON PROTEIN; ENVELOPE PROTEIN; GLUTAMINE; GLYCINE; ISOLEUCINE; LAMIN A; LEUCINE; LINKER OF NUCLEOSKELETON AND CYTOSKELETON PROTEIN COMPLEX; NUCLEAR ENVELOPE SPECTRIN REPEAT PROTEIN 2; PROLINE; UNCLASSIFIED DRUG; VALINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CYTOSKELETON; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; LAMINOPATHY; LMNA GENE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CHROMATIN; COS CELLS; CYTOSKELETON; GENETIC DISEASES, INBORN; HUMANS; LAMIN TYPE A; MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NERVE TISSUE PROTEINS; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT;

EID: 84882573661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071850     Document Type: Article

References (68)

1. Malhas A, Goulbourne C, Vaux DJ, (2011) The nucleoplasmic reticulum: form and function. Trends Cell Biol 21: 362-373.
2. Taranum S, Sur I, Muller R, Lu W, Rashmi RN, et al. (2012) Cytoskeletal interactions at the nuclear envelope mediated by nesprins. Int J Cell Biol 2012: 736524.
3. Lu W, Schneider M, Neumann S, Jaeger VM, Taranum S et al. (2012) Nesprin interchain associations control nuclear size. Cell Mol Life Sci.
4. Mellad JA, Warren DT, Shanahan CM, (2011) Nesprins LINC the nucleus and cytoskeleton. Curr Opin Cell Biol 23: 47-54.
5. Lu W, Gotzmann J, Sironi L, Jaeger VM, Schneider M, et al. (2008) Sun1 forms immobile macromolecular assemblies at the nuclear envelope. Biochim Biophys Acta 1783: 2415-2426.
6. Crisp M, Liu Q, Roux K, Rattner JB, Shanahan C, et al. (2006) Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol 172: 41-53.
7. Worman HJ, Bonne G, (2007) "Laminopathies": a wide spectrum of human diseases. Exp Cell Res 313: 2121-2133.
8. Ho CY, Lammerding J, (2012) Lamins at a glance. J Cell Sci 125: 2087-2093.
9. Dittmer TA, Misteli T, (2011) The lamin protein family. Genome Biol 12: 222.
10. Bertrand AT, Chikhaoui K, Yaou RB, Bonne G, (2011) Clinical and genetic heterogeneity in laminopathies. Biochem Soc Trans 39: 1687-1692.
11. Kandert S, Luke Y, Kleinhenz T, Neumann S, Lu W, et al. (2007) Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells. Hum Mol Genet 16: 2944-2959.
12. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, et al. (2004) Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113: 370-378.
13. Rashmi RN, Eckes B, Glockner G, Groth M, Neumann S, et al. (2012) The nuclear envelope protein Nesprin-2 has roles in cell proliferation and differentiation during wound healing. Nucleus 3: 172-186.
14. Neumann S, Schneider M, Daugherty RL, Gottardi CJ, Eming SA, et al. (2010) Nesprin-2 interacts with {alpha}-catenin and regulates Wnt signaling at the nuclear envelope. J Biol Chem 285: 34932-34938.
15. Capanni C, Mattioli E, Columbaro M, Lucarelli E, Parnaik VK, et al. (2005) Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum Mol Genet 14: 1489-1502.
16. Clements L, Manilal S, Love DR, Morris GE, (2000) Direct interaction between emerin and lamin A. Biochem Biophys Res Commun. 267: 709-714.
17. Haque F, Lloyd DJ, Smallwood DT, Dent CL, Shanahan CM, et al. (2006) SUN1 interacts with nuclear lamin A and cytoplasmic nesprins to provide a physical connection between the nuclear lamina and the cytoskeleton. Mol Cell Biol 26: 3738-3751.
18. Ivorra C, Kubicek M, Gonzalez JM, Sanz-Gonzalez SM, Alvarez-Barrientos A, et al. (2006) A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev 20: 307-320.
19. Lloyd DJ, Trembath RC, Shackleton S, (2002) A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 11: 769-777.
20. Taniura H, Glass C, Gerace L, (1995) A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 131: 33-44.
21. Mariappan I, Gurung R, Thanumalayan S, Parnaik VK, (2007) Identification of cyclin D3 as a new interaction partner of lamin A/C. Biochem Biophys Res Commun 355: 981-985.
22. Libotte T, Zaim H, Abraham S, Padmakumar VC, Schneider M, et al. (2005) Lamin A/C-dependent localization of Nesprin-2, a giant scaffolder at the nuclear envelope. Mol Biol Cell 16: 3411-3424.
23. Rajgor D, Mellad JA, Autore F, Zhang Q, Shanahan CM, (2012) Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds. PLoS One 7: e40098.
24. Simpson JG, Roberts RG, (2008) Patterns of evolutionary conservation in the nesprin genes highlight probable functionally important protein domains and isoforms. Biochem Soc Trans 36: 1359-1367.
25. Roux KJ, Crisp ML, Liu Q, Kim D, Kozlov S, et al. (2009) Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A 106: 2194-2199.
26. Wilhelmsen K, Litjens SH, Kuikman I, Tshimbalanga N, Janssen H, et al. (2005) Nesprin-3, a novel outer nuclear membrane protein, associates with the cytoskeletal linker protein plectin. J Cell Biol 171: 799-810.
27. Vytopil M, Ricci E, Dello Russo A, Hanisch F, Neudecker S, et al. (2002) Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy. Neuromuscul Disord 12: 958-963.
28. Capanni C, Cenni V, Mattioli E, Sabatelli P, Ognibene A, et al. (2003) Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription. Exp Cell Res 291: 122-134.
29. Dutour A, Roll P, Gaborit B, Courrier S, Alessi MC, et al. (2011) High prevalence of laminopathies among patients with metabolic syndrome. Hum Mol Genet 20: 3779-3786.
30. Brauch KM, Chen LY, Olson TM, (2009) Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation. Am J Cardiol 103: 1426-1428.
31. Haque WA, Oral EA, Dietz K, Bowcock AM, Agarwal AK, et al. (2003) Risk factors for diabetes in familial partial lipodystrophy, Dunnigan variety. Diabetes Care 26: 1350-1355.
32. Caron M, Auclair M, Donadille B, Bereziat V, Guerci B, et al. (2007) Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ 14: 1759-1767.
33. Decaudain A, Vantyghem MC, Guerci B, Hecart AC, Auclair M, et al. (2007) New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab 92: 4835-4844.
34. Moller DV, Pham TT, Gustafsson F, Hedley P, Ersboll MK, et al. (2009) The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 11: 1031-1035.
35. Kapinos LE, Schumacher J, Mucke N, Machaidze G, Burkhard P, et al. (2010) Characterization of the head-to-tail overlap complexes formed by human lamin A, B1 and B2 "half-minilamin" dimers. J Mol Biol 396: 719-731.
36. Broers JL, Machiels BM, van Eys GJ, Kuijpers HJ, Manders EM, et al. (1999) Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J Cell Sci 112 (Pt 20): 3463-3475.
37. Gluzman Y, (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23: 175-182.
38. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
39. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
40. Gouet P, Courcelle E, Stuart DI, Metoz F, (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.
41. Wang Z, Eickholt J, Cheng J, (2010) MULTICOM: a multi-level combination approach to protein structure prediction and its assessments in CASP8. Bioinformatics 26: 882-888.
42. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE, (2002) Structure of the globular tail of nuclear lamin. J Biol Chem 277: 17381-17384.
43. Williams C, Hoppe HJ, Rezgui D, Strickland M, Forbes BE, et al. (2012) An exon splice enhancer primes IGF2: IGF2R binding site structure and function evolution. Science 338: 1209-1213.
44. Guex N, Peitsch MC, (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
45. Zhen YY, Libotte T, Munck M, Noegel AA, Korenbaum E, (2002) NUANCE, a giant protein connecting the nucleus and actin cytoskeleton. J Cell Sci 115: 3207-3222.
46. Dahl KN, Ribeiro AJ, Lammerding J, (2008) Nuclear shape, mechanics, and mechanotransduction. Circ Res 102: 1307-1318.
47. Vigouroux C, Auclair M, Dubosclard E, Pouchelet M, Capeau J, et al. (2001) Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene. J Cell Sci 114: 4459-4468.
48. Taranum S, Vaylann E, Meinke P, Abraham S, Yang L, et al. (2012) LINC complex alterations in DMD and EDMD/CMT fibroblasts. Eur J Cell Biol 91: 614-628.
49. Paradisi M, McClintock D, Boguslavsky RL, Pedicelli C, Worman HJ, et al. (2005) Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. BMC Cell Biol 6: 27.
50. Chambliss AB, Khatau SB, Erdenberger N, Robinson DK, Hodzic D, et al. (2013) The LINC-anchored actin cap connects the extracellular milieu to the nucleus for ultrafast mechanotransduction. Sci Rep 3: 1087.
51. Khatau SB, Hale CM, Stewart-Hutchinson PJ, Patel MS, Stewart CL, et al. (2009) A perinuclear actin cap regulates nuclear shape. Proc Natl Acad Sci U S A 106: 19017-19022.
52. Heessen S, Fornerod M, (2007) The inner nuclear envelope as a transcription factor resting place. EMBO Rep 8: 914-919.
53. Horton JD, Goldstein JL, Brown MS, (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
54. Guillet-Deniau I, Mieulet V, Le Lay S, Achouri Y, Carre D, et al. (2002) Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression. Diabetes 51: 1722-1728.
55. Rome S, Lecomte V, Meugnier E, Rieusset J, Debard C, et al. (2008) Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle. Physiol Genomics 34: 327-337.
56. Zaremba-Czogalla M, Dubinska-Magiera M, Rzepecki R, (2011) Laminopathies: the molecular background of the disease and the prospects for its treatment. Cell Mol Biol Lett 16: 114-148.
57. Hubner S, Eam JE, Wagstaff KM, Jans DA, (2006) Quantitative analysis of localization and nuclear aggregate formation induced by GFP-lamin A mutant proteins in living HeLa cells. J Cell Biochem 98: 810-826.
58. Sylvius N, Hathaway A, Boudreau E, Gupta P, Labib S, et al. (2008) Specific contribution of lamin A and lamin C in the development of laminopathies. Exp Cell Res 314: 2362-2375.
59. Bechert K, Lagos-Quintana M, Harborth J, Weber K, Osborn M, (2003) Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells. Exp Cell Res 286: 75-86.
60. Maraldi NM, Capanni C, Cenni V, Fini M, Lattanzi G, (2011) Laminopathies and lamin-associated signaling pathways. J Cell Biochem 112: 979-992.
61. Akhtar A, Gasser SM, (2007) The nuclear envelope and transcriptional control. Nat Rev Genet 8: 507-517.
62. Stierle V, Couprie J, Ostlund C, Krimm I, Zinn-Justin S, et al. (2003) The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 42: 4819-4828.
63. Dessalle K, Euthine V, Chanon S, Delarichaudy J, Fujii I, et al. (2012) SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors. PLoS One 7: e50878.
64. Lecomte V, Meugnier E, Euthine V, Durand C, Freyssenet D, et al. (2010) A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation. Mol Cell Biol 30: 1182-1198.
65. Wang X, Sato R, Brown MS, Hua X, Goldstein JL, (1994) SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77: 53-62.
66. Wang X, Briggs MR, Hua X, Yokoyama C, Goldstein JL, et al. (1993) Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 268: 14497-14504.
67. Harvey PA, Leinwand LA, (2011) The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol 194: 355-365.
68. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, et al. (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366: 619-628.